STEER World, a global leader in advanced materials platform technology, has successfully demonstrated a 200 kg/hour continuous run of Metformin granules using its patented INTEGRAAL Continuous Granulation System. The system delivered two high-capacity runs with consistent quality, efficiency, and operational simplicity, setting a new benchmark for scalability and sustainability in oral solid dosage (OSD) manufacturing.

The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules. Benefits include over 50% reduction in conversion costs, significant energy and carbon footprint savings, reduced QA/QC overheads, and the ability to manufacture diverse products on a single line.

“This is more than a technological achievement; it is the beginning of a new era for pharmaceutical manufacturing,” said Indu Bhushan, CEO & Director, STEER World’s Lifesciences division. “Our 200 kg/hour continuous granulation system is a testament to our commitment to innovation, offering the industry a viable and transformative path toward a future that is faster, cleaner, and more efficient. We are proud to lead this paradigm shift and help our partners deliver life-saving medicines to the world with unprecedented speed and quality.”

“INTEGRAAL offers a unique opportunity for manufacturers to achieve strong bottom-line and top-line growth,” added Rajesh Srinivasan, Chief Development Officer, STEER World. “They can now operate granulation lines continuously at high capacities, delivering the exact quality needed every minute. This capability fundamentally changes the economics and performance of pharmaceutical manufacturing.”

The achievement is expected to accelerate adoption of continuous manufacturing globally, providing a more efficient, cost-effective, and environmentally friendly solution for high-volume pharmaceutical production.